US 7470431
Use of neurotoxin therapy for treatment of urological-neurological disorders associated with prostate cancer
granted A61KA61K38/164A61K38/4886
Quick answer
US patent 7470431 (Use of neurotoxin therapy for treatment of urological-neurological disorders associated with prostate cancer) held by The Regents of the University of Colorado expires Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado
- Grant date
- Tue Dec 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K38/164, A61K38/4886, A61K38/4893